Literature DB >> 28364991

Polypharmacy and Delirium in Critically Ill Older Adults: Recognition and Prevention.

Erik Garpestad1, John W Devlin2.   

Abstract

Among older adults, polypharmacy is a sequelae of admission to the intensive care unit and is associated with increased medication-associated adverse events, drug interactions, and health care costs. Delirium is prevalent in critically ill geriatric patients and medications remain an underappreciated modifiable risk for delirium in this setting. This article reviews the literature on polypharmacy and delirium, with a focus on highlighting the relationships between polypharmacy and delirium in critically ill, older adults. Discussed are clinician strategies on how to recognize and reduce medication-associated delirium and recommendations that help prevent polypharmacy when interventions to reduce the burden of delirium in this vulnerable population are being formulated.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antipsychotic agents; Benzodiazepine; Delirium; Intensive care; Medications; Older adults; Polypharmacy; Prevention

Mesh:

Year:  2017        PMID: 28364991     DOI: 10.1016/j.cger.2017.01.002

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  7 in total

1.  Approaches to Optimize Medication Data Analysis in Clinical Cohort Studies.

Authors:  Matthew S Duprey; John W Devlin; Becky A Briesacher; Thomas G Travison; John L Griffith; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2020-10-01       Impact factor: 5.562

2.  Predisposing and precipitating factors for delirium in neurology: a prospective cohort study of 1487 patients.

Authors:  Carl Moritz Zipser; Jeremy Deuel; Jutta Ernst; Maria Schubert; Michael Weller; Roland von Känel; Soenke Boettger
Journal:  J Neurol       Date:  2019-09-13       Impact factor: 4.849

3.  Characterization of Nocturnal Neuroactive Medication Use and Related Sleep Documentation in Critically Ill Adults.

Authors:  Arzo Hamidi; Russel J Roberts; Gerald L Weinhouse; Paul M Szumita; Jeremy R Degrado; Kevin M Dube; Mary P Kovacevic; Mia Choi; Regan Sevinsky; Matthew S Duprey; John W Devlin
Journal:  Crit Care Explor       Date:  2021-03-15

Review 4.  Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions.

Authors:  M Kurczewska-Michalak; P Lewek; B Jankowska-Polańska; A Giardini; N Granata; M Maffoni; E Costa; L Midão; P Kardas
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

Review 5. 

Authors:  Olivia Geen; Bram Rochwerg; Xuyi Mimi Wang
Journal:  CMAJ       Date:  2021-12-06       Impact factor: 8.262

Review 6.  Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS.

Authors:  Shahideh Amini; Aysa Rezabakhsh; Javad Hashemi; Fatemeh Saghafi; Hossein Azizi; Antoni Sureda; Solomon Habtemariam; Hamid Reza Khayat Kashani; Zahra Hesari; Adeleh Sahebnasagh
Journal:  J Intensive Care       Date:  2022-07-30

Review 7.  Optimizing care for critically ill older adults.

Authors:  Olivia Geen; Bram Rochwerg; Xuyi Mimi Wang
Journal:  CMAJ       Date:  2021-10-04       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.